Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020
MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a...
Day: November 16, 2020
Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
First patients on track for enrollment this year Targeting multi-billion market with no approved therapies for cancer-related anorexia LA JOLLA,...
Vaxart Hosting Key Opinion Leader Panel Call for Investors
Title: An Oral Tablet Vaccine – A Potential Global Solution to COVID-19 and Norovirus Key topics:COVID-19: Immunity & Immunological MemoryNorovirus:...
PDS Biotech Announces New and Broad Versamune® Platform Patent Claims
Granted methods patent for Versamune® platform by the United States Patent and Trademark Office FLORHAM PARK, N.J., Nov. 16, 2020...
Exagen and GSK partner for 4th straight year, driving greater awareness of challenges facing lupus diagnosis and management
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum...
Cocrystal Pharma Reports Third Quarter 2020 Financial Results and Provides Update on Antiviral Programs
– Continued progress of COVID-19 development programs with additional preclinical studies of coronavirus protease inhibitors (3CL) underway and lead preclinical...
Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
- Company to receive upfront payment of €5 million replacing a later stage regulatory approval milestone of U.S.$5 million -...
Ziopharm Oncology Appoints Mary Thistle to Board of Directors
– Special Advisor and Former Chief of Staff for the Bill & Melinda Gates Medical Research Institute Joins as Independent...
Quanta to Participate in Upcoming Virtual Investor Conferences
ALCESTER, United Kingdom, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical...
CRISPR Therapeutics to Participate in the Jefferies Virtual London Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Philips continues its top ranking in the Dow Jones Sustainability Indices
CLC South-Africa Bouwdokken Refurbishment Process MRI November 16, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a...
Alimera Sciences Announces Participation at the 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
ATLANTA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development...
Receptor Life Sciences Receives Schedule I Research License from U.S. Drug Enforcement Agency
SEATTLE, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Receptor Life Sciences announced today that the Company was granted a Schedule I...
Viemed Healthcare to Present at Stifel Virtual Healthcare Conference on November 18, 2020
LAFAYETTE, La., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home...
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB) and Door Pharmaceuticals, LLC today announced...
Brickell Biotech to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
BOULDER, Colo., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...
New Data from the Interim Analysis of REGENERATE Show OCA Improved Noninvasive Measures of Fibrosis in a Subgroup of High-Risk Patients with Fibrosis Due to NASH
Multiple new analyses reinforce the clinical value of noninvasive strategies to identify and monitor patients with advanced fibrosis due to...
Merus to Present at the Jefferies Virtual London Healthcare Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage oncology company developing innovative,...
Abpro Announces Peer-Reviewed Publication Demonstrating Efficacy of its Neutralizing Antibody Therapeutic Against COVID-19
▪ Data from the monkey challenge study published in Nature Communications showed a single dose of neutralizing antibody ABP 300...
RAPT Therapeutics Reports Third Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...